Insider · CIK 0001581198
Darrin Beaupre
Files at IDYA (IDEAYA Biosciences, Inc.). First filing -, latest -.
In brief
Darrin Beaupre files SEC Form 4 as officer at IDYA (IDEAYA Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Darrin Beaupre has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | IDYA IDEAYA Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +175,000 | $0.00 | $0 | 175,000 | Feb 2, 2026 |
| Feb 27, 2025 | IDYA IDEAYA Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +185,000 | $0.00 | $0 | 185,000 | Feb 28, 2025 |
| Mar 1, 2024 | IDYA IDEAYA Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +160,000 | $0.00 | $0 | 160,000 | Mar 4, 2024 |
Questions about Darrin Beaupre
Answered from the filings on this page, as of the latest one.
Is Darrin Beaupre buying or selling?
Darrin Beaupre has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Darrin Beaupre's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Darrin Beaupre has 0.
Where does Darrin Beaupre file Form 4?
Darrin Beaupre has filed Form 4 at IDYA (IDEAYA Biosciences, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.